Global Encephalopathy Treatment Market 2019-2023

Global Encephalopathy Treatment Market 2019-2023

About Encephalopathy

Encephalopathy is a disease that affects the functioning and structure of the brain. It can be temporary, permanent, or neonatal.

Technavio’s analysts forecast the Global Encephalopathy Treatment Market to grow at a CAGR of 4.75% during the period 2019-2023.

Covered in this report

The report covers the present scenario and the growth prospects of the encephalopathy treatment market. To calculate the market size, the report considers the revenue generated by the sale of drugs for the treatment of encephalopathy across the globe.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, encephalopathy treatment market 2019-2023, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Key vendor
  • Bausch Health
Market driver
  • Rise in initiatives to increase the awareness about encephalopathy disease management
  • For a full, detailed list, view our report
Market challenge
  • Adverse effects associated with available drugs
  • For a full, detailed list, view our report
Market trend
  • Emergence of novel treatment targets for encephalopathy
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2023 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


PRESS RELEASE

Technavio Announces the Publication of its Research Report - Global Encephalopathy Treatment Market 2019-2023

Technavio recognizes the following company as the key player in the global encephalopathy treatment market: Bausch Health.

Commenting on the report, an analyst from Technavio’s team said: “One trend affecting this market is the emergence of novel treatment targets for encephalopathy. Certain candidates are under investigation for the treatment of liver cirrhosis which is one of the leading causes of hepatic encephalopathy.”

According to the report, one driver influencing this market is the driven by the rise in initiatives to increase the awareness about encephalopathy disease management and effective treatment of encephalopathy. Most of the programs aim at providing co-pay assistance, educational material for hepatic encephalopathy, and treatment adherence support. The growing availability of such patient awareness programs for assistance in the management and treatment of encephalopathy is expected to boost the growth of the global encephalopathy market.

Further, the report states that one challenge affecting this market is the adverse side effects associated with available drugs. The growth of the market is impeded by the adverse side effects such as severe stomach pain, diarrhea, and flatulence due to the available drugs for the treatment of encephalopathy.

Companies Mentioned

Bausch Health

  • Executive summary
  • Scope of the report
  • Market landscape
    • Market ecosystem
      • Table Global CNS disorder drugs market
      • Table Segments of global cns disorder drugs market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Pipeline Analysis
    • Table Pipeline drugs under phase I/II development
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2018
      • Table Market size 2018
    • Market size and forecast 2018-2023
      • Table Global market: Size and forecast 2018-2023 ($ millions)
      • Table Global market: Year-over-year growth 2019-2023 (%)
  • Five forces analysis
    • Table Five forces analysis 2018
    • Table Five forces analysis 2023
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2018
  • Market segmentation by type
    • Table Type - Market share 2018-2023 (%)
    • Comparison by type
      • Table Comparison by type
    • Hepatic encephalopathy - Market size and forecast 2018- 2023
      • Table Hepatic encephalopathy - Market size and forecast 2018-2023 ($ millions)
      • Table Hepatic encephalopathy - Year-over-year growth 2019-2023 (%)
    • Diabetic encephalopathy - Market size and forecast 2018- 2023
      • Table Diabetic encephalopathy - Market size and forecast 2018-2023 ($ millions)
      • Table Diabetic encephalopathy - Year-over-year growth 2019-2023 (%)
    • Infectious encephalopathy - Market size and forecast 2018- 2023
      • Table Infectious encephalopathy - Market size and forecast 2018-2023 ($ millions)
      • Table Infectious encephalopathy - Year-over-year growth 2019-2023 (%)
    • Others - Market size and forecast 2018-2023
      • Table Others - Market size and forecast 2018-2023 ($ millions)
      • Table Others - Year-over-year growth 2019-2023 (%)
    • Market opportunity by type
      • Table Market opportunity by type
  • Customer landscape
    • Table Customer landscape
  • Geographic landscape
    • Geographic segmentation
      • Table Market share by geography 2018-2023 (%)
    • Geographic comparison
      • Table Geographic comparison
    • Americas - Market size and forecast 2018-2023
      • Table Americas - Market size and forecast 2018-2023 ($ millions)
      • Table Americas - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in Americas
    • EMEA - Market size and forecast 2018-2023
      • Table EMEA - Market size and forecast 2018-2023 ($ millions)
      • Table EMEA - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in EMEA
    • APAC - Market size and forecast 2018-2023
      • Table APAC - Market size and forecast 2018-2023 ($ millions)
      • Table APAC - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in APAC
    • Key leading countries
      • Table Key leading countries
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
      • Table Impact of drivers and challenges
  • Market Trends
    • Emergence of novel treatment targets for encephalopathy
    • Increase in FDA drug approval for diseases associated with encephalopathy
    • Increase in adoption of technological advances for treating encephalopathy
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • Bausch Health
      • Table Bausch Health - Vendor overview
      • Table Bausch Health - Business segments
      • Table Bausch Health - Organizational developments
      • Table Bausch Health - Geographic focus
      • Table Bausch Health - Segment focus
      • Table Bausch Health - Key offerings
  • Appendix
    • Research methodology
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook